Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STEPIn: Secukinumab vs nb-UVB in Early Psoriasis
NCT03020199Phase 4Completed
- Sponsor
- Novartis
- Start
- Mar 2017
- Primary completion
- Nov 2021
- Modality
- Monoclonal Antibodies
- Countries
- 13
01
Overview
A Phase 4 trial of secukinumab in plaque psoriasis, sponsored by Novartis. Started Mar 2017; status: completed.
02
Drugs
secukinumab
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT03020199.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03020199.